NCT00264472View on ClinicalTrials.gov

A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors

PHASE1SuspendedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

June 30, 2009

Conditions
Neoplasms
Interventions
DRUG

ADH300004

5 mg

Trial Locations (1)

37203

Sarah Cannon Research Institute, Nashville

Sponsors
All Listed Sponsors
lead

Adherex Technologies, Inc.

INDUSTRY

NCT00264472 - A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors | Biotech Hunter | Biotech Hunter